PLPL -study shows benefits to Breast Cancer Patients: Could

New Post Public Reply Private Reply Replies (0) Message Board
TradeForProfits
PLPL -study shows benefits to Breast Cancer Patients: Could Benefit From Plandai Phytofare(TM) Citrus Products


BALTIMORE, MD--(Marketwired - Sep 17, 2013) - Goldman Small Cap Research, a stock market research firm focused on the small cap and microcap sectors, notes that with October (The Breast Cancer Awareness Month) around the corner, it is interesting to note that Plandaí Biotechnology, Inc.'s (OTCQB: PLPL) Phytofare™ Citrus Products may prove to be useful in the fight against breast cancer due to the high bioavailability of its citrus bioflavonoid product.
For example, many breast cancer patients who undergo surgery to treat breast cancer suffer from a common side effect known as Lymphedema. This condition is marked by intense swelling of the arm due to damage done to the lymph nodes in the surgical procedure. An older study from about 15 years ago demonstrated significantly less swelling in patients who took a bioflavonoid supplement in a double blind study of 57 women. (Pecking AP, Fevrier B, Wargon C, et al. Efficacy of Daflon 500 mg in the treatment of lymphedema (secondary to conventional therapy of breast cancer). Angiology 1997; 48:93-98)
Bioflavonoids are naturally occurring compounds extracted from plants and rich in antioxidants and are found in fruits like lemons that contain vitamins A & C and a variety of minerals including potassium and pectin. These bioflavonoids help protect the nutrients from oxidation in the body. To that end, Plandaí is set to release the Phytofare™ Catechin Complex in the coming months and the citrus-based Limonoid Glycoside Complex products in 2014. The Phytofare™ citrus bioflavonoid product will be 7 to 12 times more effective from a blood absorption perspective than any other bioflavonoid supplement on the market today. Using dietary supplements similar to this has been shown effective in treating all sorts or ailments and sicknesses like Lymphedema in the past.
Fast forward to today where many organizations like BreastCancer.org are recommending dietary supplements and general diets that include citrus bioflavonoids to aid in fighting the effects of Lymphedema. Unfortunately, Lymphedema will continue to be a common problem as breast cancer remains a huge issue in women's health and bioflavonoids in generally have very poor bioavailability -- often around 5% absorption. That can dramatically change due to the high bioavailability associated with its citrus bioflavonoid product.
Breast cancer remains at the forefront of women's health concerns. According to American Cancer Society an estimated 1 in 8 women will be diagnosed with breast cancer in their lifetime and over 235,000 women expected to be diagnosed per year in and approximately 40,000 will die from the disease.
Breast cancer surgery remains a very popular treatment in fighting the disease. Lymphedema occurs as a side effect of this surgery in some cases but also occurs in a larger cross section of society in general. The Plandaí Phytofare™ Citrus product will aid symptoms of this ailment and provide better results than competitors because of its superior bioavailability, or absorption in the blood, as mentioned above. This market is yet another that should help Plandaí generate revenue as the Company ramps up production by year-end 2013 and into 2014.
Goldman Small Cap Research sponsored articles, reports, and updates on Plandai as well as associated disclaimers and disclosures can be accessed or downloaded in their entirety by visiting www.goldmanresearch.com.
About Goldman Small Cap Research: Led by former Piper Jaffray analyst and mutual fund manager Rob Goldman, Goldman Small Cap Research produces sponsored and non-sponsored small cap and micro cap stock research reports, articles, daily stock market blogs, and popular investment newsletters. Goldman Small Cap Research is not in any way affiliated with Goldman Sachs & Co.
A Goldman Small Cap Research report, update, newsletter, or article is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed. Please read all associated full disclosures, disclaimers, and analyst background on our website before investing. Neither Goldman Small Cap Research nor its parent is a registered investment adviser or broker-dealer with FINRA or any other agency. To download our research, view our disclosures, or for more information, visit www.goldmanresearch.com.
About Plandai Biotechnology, Inc. (OTCQB: PLPL): Plandai Biotechnology, Inc. and its subsidiaries develop highly bioavailable, phytonutrient rich extracts, which are being utilized to deliver a new family of drugs to safely and affordably treat a multitude of diseases and conditions. Plandai Biotechnology controls every aspect of the process, from growing the raw materials on its farms in South Africa, to producing the patented pending Phytofare™ extracts in-house allowing the Company to guarantee the continuity of supply as well as quality control throughout targeted industries for the Company's products include food and beverage, cosmeceutical, wellness, nutraceutical, anti-aging, and pharmaceutical. For more information, please visit http://www.plandaibiotech.com.
Contact:
Goldman Small Cap Research
Rob Goldman
Analyst
410-609-7100
rob@goldmanresearch.com
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Investors Gear Up for Lennar Class Action Lawsuit

Updated Category News Views 379

High Stakes and Hard Hits for Lennar Stockholders There’s rarely a dull moment in the world of Wall Street, and Lennar Corporation (NYSE: LEN) is proving that rule right now. As a whiff of scandal wafts through the air, the famed homebuilder and its bigwigs are staring down the barrel of a formidable class action lawsuit. The question is, just how deep do the alleged...

Continue Reading
Pan-Mass Challenge Gifts $80M to Dana-Farber for 2026

Updated Category News Views 382

A Momentous Gift in a Crunch Time for Cancer Research Biking and philanthropy might seem like an odd duo, but let me tell you, the Pan-Mass Challenge (PMC) is making that partnership look like peanut butter and jelly. This year, PMC rolled out a jaw-dropping $80 million gift to the Dana-Farber Cancer Institute. You heard right—eighty million smackeroos. Talk about going...

Continue Reading
Berry Street Integrates AI with What Matters: Human Touch

Updated Category News Views 344

Health Meets AI at Berry Street In recent waves of news, Berry Street has decided to toss MyScribe, a standalone AI service, into its shopping cart and welcomed its brainwave behind it, Dr. Wasif Bokhari, into their corridors. Yep, they’ve snagged both the tech and the mind! It's the kind of move that makes you stop midway through your diner coffee. Here’s Berry...

Continue Reading
Bank Hapoalim's Q3 2026: Steady Growth Amid Challenges

Updated Category News Views 15

Digging Deep into Hapoalim's Recent Results Now ain't this a turn of events? Bank Hapoalim rolls out its numbers for Q3 2026, and while there's no confetti dropping from the ceiling, the numbers are telling their own story. Net profit comes to a solid NIS 2,364 million, but we're looking at a landscape that's not all rose-tinted today. The bank's managed to pull off...

Continue Reading
Guangdong's APEC Trade: Deep Ties, Big Stakes

Updated Category News Views 160

A New Chapter in Guangdong's Economic Story Swing by the bustling streets of Shenzhen, and you'll catch more than a whiff of change in the air. With China gearing up to host the APEC Economic Leaders' Meeting for the third time, Guangdong is under the magnifying glass. But it's not just the international attention landing on the province that’s worth the chatter —...

Continue Reading
Fapon's MEDICA 2026 Bid: Game-Changer or Same Old?

Updated Category News Views 59

Fapon's Ambitious Pitch at MEDICA: A Real Deal? MEDICA 2026 sees Fapon stepping up, laden with flashy promises and hardened expertise. Set up in Düsseldorf, these folks are pushing their Local Manufacturing Solutions harder than a door-to-door vacuum seller. The main pitch? Bolstering local IVD production with their comprehensive tech transfer services. How many outfits...

Continue Reading
Galileo's Robot Dog Takes Charge in Polish Warehouses

Updated Category News Views 58

Robotic Innovation Makes Waves in Europe You ever think you’d see the day when a dog—albeit a robotic one—takes the night shift at a warehouse? Well, here we are. Galileo Robotics has unleashed its C1-W robot dog in Poznan, Poland, and it's more than just a fancy tech gimmick. This thing's got potential, bridging gaps left wide open by human labor shortages and...

Continue Reading
KINGRVER Boosts RV Comfort with New Water Heater Lineup

Updated Category News Views 370

An Upgrade for the Open Road In the land of RV living, comfort is king—or in this case, KINGRVER. Dropping affordable upgrades for water heaters into the world of RVs, KINGRVER's CT6 lineup is like a warm hug on a chilly campsite morning. Whether you've pulled up to a wooded retreat or parked under the vast desert sky, having dependable hot water shouldn't be a gamble....

Continue Reading
HKEX Unveils New Offshore RMB Bond Index

Updated Category News Views 88

Here's the scoop: Hong Kong Exchanges and Clearing Limited (HKEX) just rolled out something worth eyeing—the HKEX Offshore RMB Bond Index. It's the first of its kind from HKEX, catered to those Dim Sum bonds floating around in the city. With Bloomberg lending a hand on the index smarts, this step is poised to give Hong Kong a leg up in the global financial marathon....

Continue Reading
Beef 'O' Brady's Expands Into Tuscaloosa Market

Updated Category News Views 358

A New Player in Town: Beef 'O' Brady's Lands in Tuscaloosa Listen up, sports fans and pub grub lovers of Tuscaloosa! Beef 'O' Brady's just kicked down the doors and expanded its reach, opening a location smack on McFarland Boulevard. The place threw open its doors on October 26 and is set to make waves in the local scene, driven by the dedicated hands of Mitul Patel and...

Continue Reading

Top 5 Most Recently Viewed Articles

The GEO Group Expands Services with $70 Million Investment

Updated Category News Views 182

The GEO Group's Major Investment in Service Expansion The GEO Group, Inc. (NYSE: GEO) has made headlines with its recent announcement of a substantial $70 million investment aimed at enhancing its capabilities in providing services to U.S. Immigration and Customs Enforcement (ICE). As the leading service provider for ICE, GEO currently manages approximately 21,000...

Continue Reading
NJ's $21.3M Water Fix Fights PFAS, Boosts AWK

Updated Category News Views 216

Water Woes Culminate in Triumph Alright, folks, you don't often see New Jersey in the headlines for anything groundbreaking in the right way, but here we are. The big news is a hefty $21.3 million project completion that finally puts some ammo against the notorious PFAS chemicals. If you've got any skin in the utility game or just a stake in clean water, this one's been...

Continue Reading
Volkswagen's CEO Calls for Major Union Concessions Amid Challenges

Updated Category News Views 69

Volkswagen Prepares for Union Negotiations Amid Growing Tensions Volkswagen, a major player in the automotive industry, is gearing up for important negotiations with labor unions. These talks are taking place as the company faces rising tensions and significant challenges within the industry. The CEO, Oliver Blume, anticipates that unions will propose measures focused on...

Continue Reading
Exploring the Growth of CAE Market and Key Players in 2025

Updated Category News Views 248

Overview of the Computer-Aided Engineering (CAE) Market The Computer-aided Engineering (CAE) market is experiencing significant growth, projected to reach approximately USD 19.96 billion by 2030. This remarkable rise is spurred on by a compound annual growth rate (CAGR) of 10.2% from its previous valuation of USD 12.28 billion. Driving Forces Behind Market Growth A major...

Continue Reading
Investors of RCI Hospitality Holdings Urged to Act Now

Updated Category News Views 201

Investors Alert for RCI Hospitality Holdings, Inc. Attention all investors in RCI Hospitality Holdings, Inc. (NASDAQ: RICK)! Recent developments concerning the company have raised significant concerns, particularly for shareholders who may have suffered financial losses. A class action lawsuit has been initiated and it’s essential for affected investors to be aware of...

Continue Reading